Prica & Partners provide advice and assistance on a variety of pharmaceutical law matters. Our multidisciplinary team of lawyers has considerable experience in all transactions relating to this highly specialized sector having acted as counsel to a number of pharmaceutical giants.   

We understand the environment in which our clients operate and the unique challenges involved in technology transfer.

Prica & Partners' pharmaceutical team is structured to deal with corporate, competition and regulatory, IP, and dispute resolution issues. Our lawyers regularly advise clients on a wide range of subjects including the exploitation of products, product licensing, acquisition and enforcement of patents, and compliance with Serbian and EU regulatory requirements.

In acting for acquiring and divesting companies, investors, licensors and licensees in the pharmaceutical sector we have been involved in carrying out legal due diligence, participating in negotiations, drafting licensing agreements and share transfer documentation.

In addition to product licensing and market authorization issues we also act as counsel to manufacturers in their marketing policy, and in particular with regards to marketing restrictions and distribution channels.

Our expertise includes:

  • Business sale and purchase agreements;
  • Clinical trial agreements;
  • Material transfer agreements;
  • Joint venture agreements;
  • Mergers & acquisitions and related Shareholders' agreements;
  • Distribution agreements;
  • Manufacturing agreements;
  • Non-disclosure agreements (also known as "NDA"s and "Confidentiality agreements");
  • Research & development agreements;
  • Sub-contracting agreements;
  • Supplier agreements.